How oxygen levels control red blood cell production
Control of Erythropoiesis by the Oxygen Sensor PHD2
This study is looking at how a protein called PHD2 helps control the production of red blood cells when oxygen levels change, which could lead to new treatments for blood disorders like anemia and erythrocytosis that affect many patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10846744 on NIH RePORTER |
What this research studies
This research investigates the role of a protein called PHD2 in regulating the production of red blood cells in response to oxygen levels. It focuses on how PHD2 interacts with a transcription factor, HIF-2a, to control the activation of the erythropoietin gene, which is crucial for red blood cell expansion. By understanding the mechanisms behind this process, the research aims to uncover new insights into conditions like anemia and erythrocytosis. Patients may benefit from findings that could lead to novel treatments for blood disorders related to red blood cell production.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing anemia or conditions that affect red blood cell counts.
Not a fit: Patients with stable red blood cell counts and no history of anemia or related blood disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies for patients with anemia or other blood disorders by enhancing our understanding of red blood cell production.
How similar studies have performed: Previous research has shown success in understanding the HIF pathway and its role in erythropoiesis, indicating that this approach has a foundation in established science.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Lee, Frank S — University of Pennsylvania
- Study coordinator: Lee, Frank S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.